Search research articles
Contact Us
Filters
Showing results (31-40 of 208) with videos related to
Page
of 21
Sort By:
Journal of Thoracic Disease
|
September 21, 2018
Lung adenocarcinoma patient progression with gastrointestinal metastasis response to subsequent tyrosine kinase inhibitors (TKIs) from re-biopsy of new occurring driver gene mutation
Chunhua Zhou, Binjie Yan, Liang Zeng, et al.
Lipids in Health and Disease
|
January 13, 2024
Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non-small-cell lung cancer
Li Liu, Shuo Zhang, Hai-Yan Yang, et al.
Frontiers in Immunology
|
March 23, 2023
Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments
Shanshan Chen, Jingyi Tang, Fen Liu, et al.
Frontiers in Oncology
|
November 29, 2023
Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer
Rui Zhou, Fan Tong, Yongchang Zhang, et al.
Foodborne Pathogens and Disease
|
September 24, 2011
Phenotypic characterization and prevalence of enterotoxin genes in Staphylococcus aureus isolates from outbreaks of illness in Chengdu City
Junni Tang, Cheng Tang, Juan Chen, et al.
Fitoterapia
|
December 4, 2020
Phyllanacidins A-C, three new cleistanthane diterpenoids from Phyllanthus acidus and their cytotoxicities
Hui-Chun Geng, Hong-Tao Zhu, Dong Wang, et al.
Natural Product Research
|
June 2, 2021
Phyllaciduloids E and F, two new cleistanthane diterpenoids from the leaves of <i>Phyllanthus acidus</i>
Hui-Chun Geng, Hong-Tao Zhu, Wei-Nong Yang, et al.
International Journal of Biological Sciences
|
July 31, 2019
Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers
Chuan-Huizi Chen, Nong Yang, Yongchang Zhang, et al.
Frontiers in Oncology
|
July 12, 2021
Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
Li Liu, Farhin Shaheed Kalyani, Haiyan Yang, et al.
Current Therapeutic Research, Clinical and Experimental
|
July 29, 2014
Effect of probenecid on pharmacokinetics and tolerability of olmesartan in healthy chinese volunteers
Kun-Yan Li, Yu Qiu, Yun Jiang, et al.
Page
of 21
Search research articles
Search
Showing results (31-40 of 208) with videos related to
Sort By:
Page
of 21
Journal of Thoracic Disease
|
September 21, 2018
Lung adenocarcinoma patient progression with gastrointestinal metastasis response to subsequent tyrosine kinase inhibitors (TKIs) from re-biopsy of new occurring driver gene mutation
Chunhua Zhou, Binjie Yan, Liang Zeng, et al.
Lipids in Health and Disease
|
January 13, 2024
Lipid alterations play a role in the integration of PD-1/PD-L1 inhibitors and anlotinib for the treatment of advanced non-small-cell lung cancer
Li Liu, Shuo Zhang, Hai-Yan Yang, et al.
Frontiers in Immunology
|
March 23, 2023
Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments
Shanshan Chen, Jingyi Tang, Fen Liu, et al.
Frontiers in Oncology
|
November 29, 2023
Genomic alterations associated with pseudoprogression and hyperprogressive disease during anti-PD1 treatment for advanced non-small-cell lung cancer
Rui Zhou, Fan Tong, Yongchang Zhang, et al.
Foodborne Pathogens and Disease
|
September 24, 2011
Phenotypic characterization and prevalence of enterotoxin genes in Staphylococcus aureus isolates from outbreaks of illness in Chengdu City
Junni Tang, Cheng Tang, Juan Chen, et al.
Fitoterapia
|
December 4, 2020
Phyllanacidins A-C, three new cleistanthane diterpenoids from Phyllanthus acidus and their cytotoxicities
Hui-Chun Geng, Hong-Tao Zhu, Dong Wang, et al.
Natural Product Research
|
June 2, 2021
Phyllaciduloids E and F, two new cleistanthane diterpenoids from the leaves of <i>Phyllanthus acidus</i>
Hui-Chun Geng, Hong-Tao Zhu, Wei-Nong Yang, et al.
International Journal of Biological Sciences
|
July 31, 2019
Inhibition of super enhancer downregulates the expression of KLF5 in basal-like breast cancers
Chuan-Huizi Chen, Nong Yang, Yongchang Zhang, et al.
Frontiers in Oncology
|
July 12, 2021
Prognosis and Concurrent Genomic Alterations in Patients With Advanced NSCLC Harboring MET Amplification or MET Exon 14 Skipping Mutation Treated With MET Inhibitor: A Retrospective Study
Li Liu, Farhin Shaheed Kalyani, Haiyan Yang, et al.
Current Therapeutic Research, Clinical and Experimental
|
July 29, 2014
Effect of probenecid on pharmacokinetics and tolerability of olmesartan in healthy chinese volunteers
Kun-Yan Li, Yu Qiu, Yun Jiang, et al.
Page
of 21